Target intelligence / Profile preview

TYRO protein tyrosine kinase binding protein (TYROBP)

Target
TYROBP
Molecular classification
Adapter protein, Transmembrane signaling protein, Immune receptor signaling adapter, ITAM (Immunoreceptor Tyrosine-based Activation Motif)-containing protein
01

Overview

TYRO protein tyrosine kinase binding protein (TYROBP), also known as DAP12, is a transmembrane adapter protein encoded by the TYROBP gene on human chromosome 19. It contains an immunoreceptor tyrosine-based activation motif (ITAM) in its cytoplasmic domain and serves as a crucial signaling adapter in various immune cell types including natural killer cells, neutrophils, monocytes, dendritic cells, and microglia. TYROBP non-covalently associates with multiple activating receptors, including members of the killer cell immunoglobulin-like receptor (KIR) family, TREM2, TREM1, CD300 family receptors, and others. Upon receptor engagement, TYROBP becomes tyrosine-phosphorylated, recruiting kinases like SYK and ZAP-70 to propagate activation signals. Beyond immune function, TYROBP plays important roles in bone modeling through osteoclast regulation and brain development through myelination. Pathological mutations in TYROBP cause polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy (PLOSL or Nasu-Hakola disease), a rare autosomal recessive disorder characterized by early-onset dementia and bone cysts. The protein's partnership with TREM2 has drawn particular attention in neurodegenerative disease research, as both proteins are implicated in microglial function and neuroinflammation.

Other names
DAP12 (DNAX-Activation Protein 12)KARAP (Killer-Activating Receptor-Associated Protein)Transmembrane Immune Signaling Adaptor TYROBPKiller cell activating receptor associated protein
02

Mechanism of action

TYROBP functions through non-covalent association with activating receptors on immune cell surfaces. Upon ligand binding to associated receptors, TYROBP undergoes tyrosine phosphorylation in its ITAM domain, which then recruits and activates tyrosine kinases such as ZAP-70 and SYK, leading to downstream cell activation and immune responses.

03

Biological functions

Signal transduction in immune cellsCell activation following ligand-receptor bindingImmune response mediation in myeloid cellsBone modeling and osteoclast developmentBrain myelinationInflammation regulationNeutrophil and monocyte activationNatural killer (NK) cell activationDendritic cell maturation and survivalPhagocytosis of apoptotic neurons in microgliaB cell proliferation regulation (negative)Cytoskeletal organization in osteoclastsMultinucleated giant cell formation
04

Disease associations

Polycystic Lipomembranous Osteodysplasia with Sclerosing Leukoencephalopathy (PLOSL), also known as Nasu-Hakola disease - caused by pathological mutations in TYROBPEarly-onset dementia (associated with PLOSL)Neurodegenerative diseaseNeuroinflammationPotential role in Alzheimer's disease and other dementias (through TREM2 association)
05

Safety considerations

Loss-of-function mutations cause severe neurological and skeletal disease (PLOSL)Critical role in microglial function suggests that therapeutic modulation could impact neuroinflammation and neuronal healthInvolvement in pro-inflammatory responses following nerve injuryRole in osteoclast function suggests potential bone-related effects from therapeutic intervention
06

Biomarkers

Mutations in TYROBP serve as diagnostic markers for PLOSL/Nasu-Hakola diseaseProtein's expression patterns in microglia and myeloid cells may have relevance for neuroinflammatory and neurodegenerative conditions

Beyond the preview

Go deeper on TYRO protein tyrosine kinase binding protein (TYROBP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TYRO protein tyrosine kinase binding protein (TYROBP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call